Skip to main content
SpringerLink
Log in

Voriconazole cost effective for prevention of invasive mycoses

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 US dollars

Reference

  • Morfin-Otero R, et al. Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico. ClinicoEconomics and Outcomes Research 2018: 511-520, No. 10, 6 Sep 2018. Available from: URL: https://doi.org/10.2147/CEOR.S157642

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Voriconazole cost effective for prevention of invasive mycoses. PharmacoEcon Outcomes News 812, 32 (2018). https://doi.org/10.1007/s40274-018-5299-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5299-y

Search

Navigation